Dublin, Aug. 17, 2022 (GLOBE NEWSWIRE) -- The "Cell Analysis Global Market - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
According to analysis, the cell analysis global market is expected to grow at a low single digit CAGR from 2022 to 2029 to reach $38,020.6 million by 2029. The rising incidence of infectious and non-infectious diseases and demand for early detection, diagnosis & treatment, increasing government and private funding towards cell based research, increasing advancements in cell imaging technologies to reduce the cost & time during the drug discovery process are driving the cell analysis market.
The market for cell analysis is segmented based on technique, product, application, end-user and geography. The cell analysis techniques global market is segmented into PCR, Sequencing, Microfluidics and Microarrays, Spectrometry, Microscopy, Cytometry, High Content Analysis, Electrophoresis and Others. Among the techniques, the PCR segment accounted for the largest revenue in 2022. The Sequencing segment is expected to grow at a double digit CAGR from 2022 to 2029.
The cell analysis products market is mainly segmented into consumables, instruments, software and services. Among these, consumables segment commanded the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. The software and services segment is expected to grow at a mid single digit CAGR from 2022 to 2029.
The consumables market is further sub-segmented into reagents, assay kits, microplates and others. Among the consumables sub-segments, the assay kits held the largest revenue in 2022. Reagents sub-segment is the fastest growing segment with a mid single digit CAGR from 2022 to 2029.
The application market is categorized based on processes, field, and by therapeutic area. In the process of application, the market is segmented into cellular processes, signal transduction pathways, circulating tumor cells, single-cell analysis, epigenetic target analysis, subpopulation characterization, and drug and candidate screening.
Based on field of application, the market is further segmented into forensic, therapeutics, cell imaging, biomarker research, genomic analysis, stem cell analysis, and diagnostics. Diagnostics held the largest revenue of in 2022. Stem cell analysis is the fastest-growing segment at a mid single digit from 2022 to 2029.
The end-users market is segmented into hospitals & diagnostic laboratories, academic and research institutes, contract research organizations (CROs), pharmaceuticals and biotechnology companies, cell banks, and others.
Drivers and Opportunities
Rising Incidence of Infectious and Non-Infectious Diseases and Demand for Early Detection, Diagnosis & Treatment
Increasing Government and Private Funding
Increasing Advancements in Cell Imaging Technologies Reduce the Cost and Time Consumption for the Drug Discovery Process
Growing Focus on Personalized Medicine
Introduction of Advanced Technologies in Cell Analysis
Increasing Merger and Acquisition Activities in Cell Analysis
Restraints & Threats
Lack of Skilled Personnel to Use Advanced Cell Analysis Instruments
Expensive Cell Analysis Instruments
Maintaining Consistency, Reproducibility of Assays and Lack of Standardization
Availability of Alternative Technologies
Stringent Regulatory Framework Limits Advancements in Cellular Analysis Market
Key Topics Covered:
1 Executive Summary
3 Market Analysis
4 Cell Analysis Global Market, Based on Techniques
5 Cell Analysis Global Market, Based on Products
6 Cell Analysis Global Market, Based on Application
7 Cell Analysis Global Market, Based on End-Users
8 Regional Market Analysis
9 Competitive Landscape
10 Major Player Profiles
Abbott Laboratories, Inc.
ABP Biosciences LLC
Adaptive Biotechnologies Corp.
Agilent Technologies Inc. (U.S.)
Akadeum Life Sciences
Akoya Biosciences, Inc.
Alit Lifesciences Co., Ltd
Altona Diagnostics GmbH
Analytik Jena AG (CyBio AG)
ArrayGen Technologies Pvt Ltd (India)
Art Robbins Instruments LLC (U.S.)
Aviva Bioscience (U.S.)
Axion Biosystems (CytoSMART Technologies B.V.) (U.S.)
Azenta Life Sciences (Brooks life sciences)
Becton Dickinson and Company
Berry Genomics Co., Ltd
Bio View Ltd.
BioAgilytix Labs, LLC (Cambridge Biomedical Inc.)
Bio-Rad Laboratories Inc.
Carl Zeiss AG
GC biotech B.V.
Helena Laboratories Corporation
Hettich Lab Technology
Jasco Analytical Instruments
Kinetic River Corp.
LABGENE Scientific SA
LGC Ltd (Biosearch Technologies)
LungLife AI, Inc
Meiji Techno Co., Ltd
Menarini Silicon Biosystems
Micro-Shot Technology Ltd.
Miltenyil Biotec GmbH
Mission Bio, Inc.
Myllia Biotechnology (Aelian Biotechnology)
NanoString Technologies, Inc.
Scipio bioscience S.A.S
Single Cell Discoveries
Singleron Biotechnologies. Inc
Singular Genomics Systems, Inc
Tracxn Technologies Limited (Capp Aps)
Visitron Systems GmbH
Yokogawa Electric Corporation
For more information about this report visit https://www.researchandmarkets.com/r/3x17g2
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900